Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

2 results about "Antiangiogenic agents" patented technology

Conjugates comprising ocular angiogenesis growth factor aptamers and uses thereof in the detection and treatment of ophthalmological angiogenesis indications

ActiveUS12642867B2Organic active ingredientsSenses disorderAptamerOcular angiogenesis
Provided is an antiangiogenic agent in the form of a vehicle, e.g., a nanoparticle associated (directly or indirectly) with at least one ocular angiogenesis growth factor aptamer, wherein said association labile to interaction between the aptamer and an ocular angiogenesis growth factor.
Conjugates comprising ocular angiogenesis growth factor aptamers and uses thereof in the detection and treatment of ophthalmological angiogenesis indications
View all
Owner:YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD +1

Antiangiogenic Agents and Methods of Using Such Agents

PendingJP2026505594ASenses disorderImmunoglobulin superfamilyGlycineAntiangiogenic agents
The antiangiogenic agent or polypeptide has an amino acid segment substantially similar to domain 1 of CD2. The polypeptide has a β-sheet formed by the two segments. Methods of using such agents and polypeptides are also included. The agent or polypeptide has a terminal glycine.
Antiangiogenic Agents and Methods of Using Such Agents
Antiangiogenic Agents and Methods of Using Such Agents
Antiangiogenic Agents and Methods of Using Such Agents
View all
Owner:GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION INC